4.7 Article

The role of glutamate oxaloacetate transaminases in sulfite biosynthesis and H2S metabolism

Journal

REDOX BIOLOGY
Volume 38, Issue -, Pages -

Publisher

ELSEVIER
DOI: 10.1016/j.redox.2020.101800

Keywords

6): cysteine catabolism; Sulfite oxidase; Glutamate oxaloacetate transaminase; H2S; Persulfidation; sulfide:quinone oxidoreductase

Funding

  1. German Research Foundation (Deutsche Forschungsgemeinschaft, DFG) [SFB1218, 269925409, SFB1403, 414786233, TUDFO/51757/2019-ITM]
  2. Hungarian National Research, Development and Innovation Office [KH_126766, K_129286]
  3. NINDS of the National Institutes of Health [1K12NS098482-01]

Ask authors/readers for more resources

Molybdenum cofactor deficiency and isolated sulfite oxidase deficiency are rare genetic disorders caused by impairment of the mitochondrial enzyme sulfite oxidase. Investigation of the contributions of cytosolic and mitochondrial glutamate oxaloacetate transaminase (GOT) in cellular extracts revealed that the cytosolic isoform GOT1 is primarily responsible for sulfite production. Loss of sulfite oxidase activity leads to accumulation of sulfite, H2S, and persulfidated cysteine and glutathione, suggesting an increase in SQR protein levels. Surprisingly, under conditions of sulfite toxicity, none of the known H2S-producing pathways were found to be upregulated, indicating an alternative route of sulfite-induced shift from oxidative to H2S dependent cysteine catabolism.
Molybdenum cofactor deficiency and isolated sulfite oxidase deficiency are two rare genetic disorders that are caused by impairment of the mitochondrial enzyme sulfite oxidase. Sulfite oxidase is catalyzing the terminal reaction of cellular cysteine catabolism, the oxidation of sulfite to sulfate. Absence of sulfite oxidase leads to the accumulation of sulfite, which has been identified as a cellular toxin. However, the molecular pathways leading to the production of sulfite are still not completely understood. In order to identify novel treatment options for both disorders, the understanding of cellular cysteine catabolism - and its alterations upon loss of sulfite oxidase - is of utmost importance. Here we applied a new detection method of sulfite in cellular extracts to dissect the contribution of cytosolic and mitochondrial glutamate oxaloacetate transaminase (GOT) in the transformation of cysteine sulfinic acid to sulfite and pyruvate. We found that the cytosolic isoform GOT1 is primarily responsible for the production of sulfite. Moreover, loss of sulfite oxidase activity results in the accumulation of sulfite, H2S and persulfidated cysteine and glutathione, which is consistent with an increase of SQR protein levels. Surprisingly, none of the known H2S-producing pathways were found to be upregulated under conditions of sulfite toxicity suggesting an alternative route of sulfite-induced shift from oxidative to H2S dependent cysteine catabolism.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Biochemistry & Molecular Biology

Molecular mechanism of intramolecular electron transfer in dimeric sulfite oxidase

Malin Eh, Alexander Tobias Kaczmarek, Guenter Schwarz, Daniel Bender

Summary: Sulfite oxidase (SOX) is an enzyme that contains both molybdenum and heme, and is responsible for oxidizing sulfite to sulfate. It has been found that one functional subunit in SOX is sufficient for catalysis, and electrons can be transferred between different subunits.

JOURNAL OF BIOLOGICAL CHEMISTRY (2022)

Article Endocrinology & Metabolism

A defect in molybdenum cofactor binding causes an attenuated form of sulfite oxidase deficiency

Alexander Tobias Kaczmarek, Daniel Bender, Titus Gehling, Joshua Benedict Kohl, Hulya-Sevcan Daimagueler, Jose Angel Santamaria-Araujo, Max Christoph Liebau, Anne Koy, Sebahattin Cirak, Guenter Schwarz

Summary: Isolated sulfite oxidase deficiency (ISOD) is a rare metabolic disorder caused by mutations in the SUOX gene, leading to a loss of sulfite oxidase (SO) function and accumulation of harmful metabolites, resulting in severe neurodegenerative diseases. The correct insertion of heme cofactor and molybdenum cofactor into SO is crucial for its function, with deficiencies in this process contributing to the development of ISOD.

JOURNAL OF INHERITED METABOLIC DISEASE (2022)

Article Cell Biology

Peripheral Inflammatory Cytokine Signature Mirrors Motor Deficits in Mucolipidosis IV

Albert L. Misko, Laura D. Weinstock, Sitara B. Sankar, Amanda Furness, Yulia Grishchuk, Levi B. Wood

Summary: MLIV patients have significantly increased blood cytokine levels, which are related to motor dysfunction. The interferon pro-inflammatory axis is found to be important in MLIV pathology.

CELLS (2022)

Article Pharmacology & Pharmacy

Molybdenum Cofactor Catabolism Unravels the Physiological Role of the Drug Metabolizing Enzyme Thiopurine S-Methyltransferase

Julika Pristup, Elke Schaeffeler, Sita Arjune, Ute Hofmann, Jose Angel Santamaria-Araujo, Patrick Leuthold, Nele Friedrich, Matthias Nauck, Simon Mayr, Mathias Haag, Thomas Muerdter, Franz-Josef Marner, Mary Relling, William E. Evans, Guenter Schwarz, Matthias Schwab

Summary: This study identified a methyltransferase involved in urothione synthesis and revealed a novel link between molybdenum cofactor catabolism and drug metabolism. The study demonstrated that TPMT genotype and phenotype are associated with urothione excretion levels and validated these findings in a population-based study.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2022)

Article Urology & Nephrology

Microvascular perfusion, perfused boundary region and glycocalyx shedding in patients with autosomal dominant polycystic kidney disease: results from the GlycoScore III study

Alexander Fuchs, Jennifer Dederichs, Sita Arjune, Polina Todorova, Fabian Woestmann, Philipp Antczak, Anja Illerhaus, Birgit Gathof, Franziska Grundmann, Roman-Ulrich Mueller, Thorsten Annecke

Summary: The dimensions and integrity of the endothelial surface layer (ESL) are impaired in patients with ADPKD. Increased capillary density may be a compensatory mechanism for vascular dysfunction to ensure sufficient tissue perfusion and oxygenation.

CLINICAL KIDNEY JOURNAL (2023)

Article Medicine, General & Internal

Cyst Fraction as a Biomarker in Autosomal Dominant Polycystic Kidney Disease

Larina A. Karner, Sita Arjune, Polina Todorova, David Maintz, Franziska Grundmann, Thorsten Persigehl, Roman-Ulrich Mueller

Summary: Autosomal dominant polycystic kidney disease (ADPKD) is a common genetic kidney disease. The glomerular filtration rate (GFR) is not a reliable indicator of disease progression until decline begins. Kidney volumetry is often used to assess disease severity, but additional imaging markers are needed. This study examined cyst fraction as a potential marker and found that it correlated with eGFR and showed higher predictive accuracy than total kidney volume. Future clinical trials are encouraged to explore the predictive value of cyst fraction in combination with other biomarkers.

JOURNAL OF CLINICAL MEDICINE (2023)

Article Urology & Nephrology

Copeptin in autosomal dominant polycystic kidney disease: real-world experiences from a large prospective cohort study

Sita Arjune, Simon Oehm, Polina Todorova, Ron T. Gansevoort, Stephan J. L. Bakker, Florian Erger, Thomas Benzing, Volker Burst, Franziska Grundmann, Philipp Antczak, Roman-Ulrich Mueller

Summary: A new biomarker, copeptin levels, has been identified to predict the progression of ADPKD and aid in treatment decision-making for patients.

CLINICAL KIDNEY JOURNAL (2023)

Article Urology & Nephrology

Interaction Between Determinants Governing Urine Volume in Patients With ADPKD on Tolvaptan and its Impact on Quality of Life

Polina Todorova, Sita Arjune, Claudia Hendrix, Simon Oehm, Johannes Schmidt, Denise Krauss, Katharina Burkert, Volker Rolf Burst, Thomas Benzing, Volker Boehm, Franziska Grundmann, Roman-Ulrich Mueller

Summary: This study provides a detailed analysis of factors associated with the degree of polyuria caused by tolvaptan and puts them into the context of quality of life. The findings will contribute to optimized patient counseling regarding this treatment option in ADPKD.

KIDNEY INTERNATIONAL REPORTS (2023)

Article Urology & Nephrology

DKK3 as a potential novel biomarker in patients with autosomal polycystic kidney disease

Sita Arjune, Martin R. Spaeth, Simon Oehm, Polina Todorova, Stefan J. Schunk, Katharina Lettenmeier, Seung-Hun Chon, Malte P. Bartram, Philipp Antczak, Franziska Grundmann, Danilo Fliser, Roman-Ulrich Mueller

Summary: In this study, the researchers investigated whether DKK3 could improve outcome prediction in ADPKD. The results demonstrated that ADPKD patients had significantly higher uDKK3 levels, and uDKK3 correlated positively with the Mayo classification and kidney function. Although the effect was no longer significant in multivariate regression analysis adjusting for other factors, adding copeptin levels and the interaction term between copeptin and uDKK3 to the model improved the variance explanation of eGFR slope. Future studies are needed to confirm these findings, but uDKK3 appears to be an attractive candidate for improving outcome prediction in ADPKD.

CLINICAL KIDNEY JOURNAL (2023)

Article Urology & Nephrology

Cardiac Manifestations in Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD): A Single-Center Study

Sita Arjune, Franziska Grundmann, Polina Todorova, Claudia Hendrix, Roman Pfister, Henrik Ten Freyhaus, Roman-Ulrich Mueller

Summary: This study investigated the cardiac involvement in patients with ADPKD and compared them with a control group. The results showed a higher prevalence of left ventricular hypertrophy and mitral regurgitation in ADPKD patients, while the left ventricular ejection fraction was higher compared to the control group. Echocardiographic parameters were significantly associated with markers of disease progression.

KIDNEY360 (2023)

Article Cell Biology

Feasibility and impact of ketogenic dietary interventions in polycystic kidney disease KETO-ADPKD-a randomized controlled trial

Sadrija Cukoski, Christoph Heinrich Lindemann, Sita Arjune, Polina Todorova, Theresa Brecht, Adrian Kuhn, Simon Oehm, Sebastian Strubl, Ingrid Becker, Ulrike Kammerer, Jacob Alexander Torres, Franziska Meyer, Thomas Schomig, Nils Grosse Hokamp, Florian Siedek, Ingo Gottschalk, Thomas Benzing, Johannes Schmidt, Philipp Antczak, Thomas Weimbs, Franziska Grundmann, Roman-Ulrich Muller

Summary: Ketogenic dietary interventions show potential benefits in ADPKD patients by reducing body fat and liver volume, and improving kidney function. The interventions are feasible and safe.

CELL REPORTS MEDICINE (2023)

Article Urology & Nephrology

Automated Kidney and Liver Segmentation in MR Images in Patients with Autosomal Dominant Polycystic Kidney Disease: A Multicenter Study

Piotr Woznicki, Florian Siedek, Maatje D. A. van Gastel, Daniel Pinto Dos Santos, Sita Arjune, Larina A. Karner, Franziska Meyer, Liliana Lourenco Caldeira, Thorsten Persigehl, Ron T. Gansevoort, Franziska Grundmann, Bettina Baessler, Roman-Ulrich Mueller

Summary: The deep learning model developed in this study enables accurate segmentation of kidneys and liver, providing an objective assessment of TKV and TLV. Importantly, this method has been validated with MRI scans from 40 different scanners, making it feasible for implementation in clinical routine care.

KIDNEY360 (2022)

Meeting Abstract Transplantation

COPEPTIN AS A POTENTIAL BIOMARKER IN PATIENTS WITH AUTOSOMAL-DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD)-UPDATE FROM THE AD(H)PKD STUDY

Simon Oehm, Sita Arjune, Philipp Antczak, Polina Todorova, Franziska Grundmann, Roman-Ulrich Mueller

NEPHROLOGY DIALYSIS TRANSPLANTATION (2022)

Meeting Abstract Transplantation

FEASIBILITY AND EFFECTIVENESS OF SHORT-TERM KETOGENIC INTERVENTIONS IN AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD): RESULTS FROM THE RESET-PKD STUDY

Simon Oehm, Konstantin Steinke, Sita Arjune, Polina Todorova, Christoph Lindemann, Fabian Woestmann, Franziska Meyer, Florian Siedek, Thomas Weimbs, Franziska Grundmann, Roman-Ulrich Mueller

NEPHROLOGY DIALYSIS TRANSPLANTATION (2022)

No Data Available